Citation Impact
Citing Papers
A polyketide synthase-peptide synthetase gene cluster from an uncultured bacterial symbiont of Paederus beetles
2002 Standout
Antitumor polyketide biosynthesis by an uncultivated bacterial symbiont of the marine sponge Theonella swinhoei
2004 Standout
Genome sequence of an industrial microorganism Streptomyces avermitilis : Deducing the ability of producing secondary metabolites
2001 StandoutNobel
Identification and functional analysis of genes controlling biosynthesis of 2-methylisoborneol
2008 StandoutNobel
Metabolic engineering for drug discovery and development
2003
Recombinant organisms for production of industrial products
2010
Engineering a polyketide with a longer chain by insertion of an extra module into the erythromycin-producing polyketide synthase
2001
The evolving role of natural products in drug discovery
2005 Standout
Nano-based smart pesticide formulations: Emerging opportunities for agriculture
2018 Standout
Computational Approach for Prediction of Domain Organization and Substrate Specificity of Modular Polyketide Synthases
2003
Organocatalytic cascade reactions as a new tool in total synthesis
2010 Standout
Natural products: A continuing source of novel drug leads
2013 Standout
Preparation of human metabolites of propranolol using laboratory‐evolved bacterial cytochromes P450
2005 StandoutNobel
Identification of a cyclohexylcarbonyl CoA biosynthetic gene cluster and application in the production of doramectin
2000
Branched-chain fatty acid requirement for avermectin production by a mutant of Streptomyces avermitilis lacking branched-chain 2-oxo acid dehydrogenase activity.
1991
Type I polyketide biosynthesis in bacteria (Part A — erythromycin biosynthesis) (1994 to 2000)
2001
Marine natural products
1990 Standout
antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences
2011 Standout
Modulation of epothilone analog production through media design
2002
Biosynthesis of polyketide metabolites
1992
Cytochrome P450 complement (CYPome) of the avermectin-producer Streptomyces avermitilis and comparison to that of Streptomyces coelicolor A3(2)
2003 StandoutNobel
Semi-synthetic DNA shuffling of aveC leads to improved industrial scale production of doramectin by Streptomyces avermitilis
2005
Degradation of the drug sodium diclofenac by Trametes versicolor pellets and identification of some intermediates by NMR
2009
Organocatalytic Enantioselective Decarboxylative Aldol Reaction of Malonic Acid Half Thioesters with Aldehydes
2013 StandoutNobel
Biosynthesis of Bioactive Microbial Metabolites and Its Application to the Structural Studies and Production of Hybrid Compounds.
1996 StandoutNobel
Building-block selectivity of polyketide synthases
2003
Biosynthesis of fatty acid and polyketide metabolites
1993
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Skipping in a Hybrid Polyketide Synthase
2002
Asymmetric Organocatalytic Domino Reactions
2007 Standout
Recombinant protein expression in Escherichia coli: advances and challenges
2014 Standout
Iterative strategies for the synthesis of deoxypropionates
2010 StandoutNobel
Chemistry and Biod iversity of the Biologically Active Natural Glycosides
2004
Quinoline, quinazoline and acridonealkaloids
2007 Standout
A New Antibiotic, Antimycin A9, Produced by Streptomyces sp. K01-0031
2005 StandoutNobel
Metabolic engineering and directed evolution for the production of pharmaceuticals
2000
Control of Avermectin Biosynthesis in Streptomyces avermitilis for the Selective Production of a Useful Component.
1995 StandoutNobel
Biosynthesis of the Angiogenesis Inhibitor Borrelidin by Streptomyces parvulus Tü4055
2004
Natural Product Hybrids as New Leads for Drug Discovery
2003 Standout
Manipulation and Analysis of Polyketide Synthases
2004
Biosynthesis and attachment of novel bacterial polyketide synthase starter units
2001
Polyketide biosynthesis: a millennium review
2001 Standout
The Impact of Bacterial Genomics on Natural Product Research
2005
Novel macrolides through genetic engineering
1999
Gold catalyzed oxycyclizations of alkynols and alkyndiols
2011
Total biosynthesis of antitumor nonribosomal peptides in Escherichia coli
2006
Analysis of the biosynthetic gene cluster for the polyether antibiotic monensin in Streptomyces cinnamonensis and evidence for the role of monB and monC genes in oxidative cyclization
2003
A crevice adjoining the ribosome tunnel: Hints for cotranslational folding
2005 StandoutNobel
Mutasynthesis‐Derived Myxalamids and Origin of the Isobutyryl‐CoA Starter Unit of Myxalamid B
2007
Bioreactor Systems in Drug Metabolism: Synthesis of Cytochrome P450-Generated Metabolites
2000
Removal of diclofenac and mefenamic acid by the white rot fungus Phanerochaete sordida YK-624 and identification of their metabolites after fungal transformation
2010
Cloning of the gene encoding avermectin B 5-O-methyltransferase in avermectin-producing Streptomyces avermitilis
1998 StandoutNobel
Untapped potential: exploiting fungi in bioremediation of hazardous chemicals
2011 Standout
Mutasynthesis of Aureonitrile: An Aureothin Derivative with Significantly Improved Cytostatic Effect
2005
Engineering specificity of starter unit selection by the erythromycin‐producing polyketide synthase
2002
The contentious nature of soil organic matter
2015 StandoutNature
DNA‐Templated Organic Synthesis: Nature's Strategy for Controlling Chemical Reactivity Applied to Synthetic Molecules
2004 Standout
Combinatorial biosynthesis of polyketides and nonribosomal peptides
2001
Paecilaminol, a New NADH-Fumarate Reductase Inhibitor, Produced by Paecilomyces sp. FKI-0550
2006 StandoutNobel
Ivermectin: 25 years and still going strong
2007 StandoutNobel
Chain initiation on the soraphen-producing modular polyketide synthase from Sorangium cellulosum
2001
The Biosynthetic Logic of Polyketide Diversity
2009 Standout
Prospects for Generating New Antibiotics
2002
Total Synthesis of Borrelidin
2007 StandoutNobel
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
2009 StandoutScience
Natural products, their derivatives, mimics and synthetic equivalents: role in agrochemical discovery
2016
The chemistry of recently isolated naturally occurring quinazolinone alkaloids
2006 Standout
Natural Product Synthesis Using Multicomponent Reaction Strategies
2009 Standout
AGROACTIVE COMPOUNDS OF MICROBIAL ORIGIN
1993 StandoutNobel
Substrate Tolerance of Module 6 of the Epothilone Synthetase
2007
Tolerance and Specificity of Polyketide Synthases
1999
Sponge-Associated Microorganisms: Evolution, Ecology, and Biotechnological Potential
2007 Standout
Mutasynthese von Aureonitril, einem Aureothin‐Derivat mit signifikant verbesserter zytostatischer Aktivität
2005
Microbial metabolites: 45 years of wandering, wondering and discovering
2011 StandoutNobel
Discovery, chemistry, and chemical biology of microbial products
2007 StandoutNobel
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Harnessing the Biosynthetic Potential of Modular Polyketide Synthases
1997
Straightforward Synthesis of α,β-Unsaturated Thioesters via Ruthenium-Catalyzed Olefin Cross-Metathesis with Thioacrylate
2008 StandoutNobel
Nitrogen regulation of fatty acids and avermectins biosynthesis inStreptomyces avermitilis
1992
Engineered Biosynthesis of Regioselectively Modified Aromatic Polyketides Using Bimodular Polyketide Synthases
2004
Avermectin Biosynthesis
1997 StandoutNobel
Concerning the Selective Protection of (Z)-1,5-syn-Ene-diols and (E)-1,5-anti-Ene-diols as Allylic Triethylsilyl Ethers
2007
Mutasynthesis of Enterocin and Wailupemycin Analogues
2003
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Streptomyces avermectinius sp. nov., an avermectin-producing strain.
2002 StandoutNobel
Gold-Catalyzed Carbon−Heteroatom Bond-Forming Reactions
2011 Standout
Antiparasitic agents produced by microorganisms
2004 StandoutNobel
New Rapamycin Derivatives by Precursor‐Directed Biosynthesis
2004
Engineering of modular polyketide synthases to produce novel polyketides
1998
A C 35 Carotenoid Biosynthetic Pathway
2003 StandoutNobel
Cationic Gold(I)-Catalyzed Intramolecular Cyclization of γ-Hydroxyalkynones into 3(2H)-Furanones
2010
Genome mining of the Streptomyces avermitilis genome and development of genome-minimized hosts for heterologous expression of biosynthetic gene clusters
2013 StandoutNobel
Gold(I)-Catalyzed Activation of Alkynes for the Construction of Molecular Complexity
2015 Standout
Organization of the biosynthetic gene cluster for the polyketide anthelmintic macrolide avermectin in Streptomyces avermitilis
1999
Works of MICHAEL S. PACEY being referenced
Avermectins and flea control: structure–activity relationships and the selection of selamectin for development as an endectocide for companion animals
2000
Novel Erythromycins from a Recombinant Saccharopolyspora erythraea Strain NRRL 2338 pIG1. I. Fermentation, Isolation and Biological Activity.
1998
Structural Elucidation of a Novel Erythromycin, 13-Cyclopentyl-13-desethyl-erythromycin B, from a Recombinant Saccharopolyspora erythraea Strain, NRRL 2338 pIG/1.
1999
Microbial oxidative metabolism of diclofenac: production of 4′-hydroxydiclofenac using Epiccocum nigrum IMI354292
1998
Novel avermectins produced by mutational biosynthesis.
1991
Preparation of 13-epi-Selamectin by Biotransformation Using a Blocked Mutant of Streptomyces avermitilis.
2000
Metabolites of the higher fungi. Part 31.1 Longianone, a C7H6O4 spiro bicyclic lactone from the fungus Xylaria longiana (Rehm.)
1999
UK-63,052 complex, new quinomycin antibiotics from Streptomyces braegensis subsp. japonicus; Taxonomy, fermentation, isolation, characterisation and antimicrobial activity.
1989
C-13.BETA.-Acyloxymilbemycine, a new family of macrolides. Discovery, structural determination and hological properties.
1992